102 related articles for article (PubMed ID: 21299973)
1. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma.
Sanai N
World Neurosurg; 2010 Jul; 74(1):4-5. PubMed ID: 21299973
[No Abstract] [Full Text] [Related]
2. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Pellin A; Lopez-Guerrero JA; Callaghan R; Benito R; Roldan P; Piquer J; Llacer J; Barbera J
Clin Neuropathol; 2005; 24(5):209-18. PubMed ID: 16167544
[TBL] [Abstract][Full Text] [Related]
3. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.
Nigro JM; Misra A; Zhang L; Smirnov I; Colman H; Griffin C; Ozburn N; Chen M; Pan E; Koul D; Yung WK; Feuerstein BG; Aldape KD
Cancer Res; 2005 Mar; 65(5):1678-86. PubMed ID: 15753362
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report.
Joo M; Park SH; Chang SH; Kim H; Choi CY; Lee CH; Lee BH; Hwang YJ
Hum Pathol; 2013 Feb; 44(2):282-8. PubMed ID: 23058249
[TBL] [Abstract][Full Text] [Related]
5. Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas.
Köhler B; Wolter M; Blaschke B; Reifenberger G
Int J Cancer; 2004 Sep; 111(4):644-5. PubMed ID: 15239147
[No Abstract] [Full Text] [Related]
6. MRI study identifies three subtypes of glioblastoma.
Brower V
Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26365415
[No Abstract] [Full Text] [Related]
7. [Classification of glioblastoma and genome profiling].
de Tayrac M; Mosser J
Neurochirurgie; 2010 Dec; 56(6):464-6. PubMed ID: 20869091
[No Abstract] [Full Text] [Related]
8. KLF6 is not the major target of chromosome 10p losses in glioblastomas.
Montanini L; Bissola L; Finocchiaro G
Int J Cancer; 2004 Sep; 111(4):640-1. PubMed ID: 15239145
[No Abstract] [Full Text] [Related]
9. A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component.
Gadji M; Crous-Tsanaclis AM; Mathieu D; Mai S; Fortin D; Drouin R
Neuropathology; 2014 Apr; 34(2):170-8. PubMed ID: 24118308
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).
Nakamura H; Makino K; Kuratsu J
Brain Tumor Pathol; 2011 Jul; 28(3):185-90. PubMed ID: 21629979
[TBL] [Abstract][Full Text] [Related]
11. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
Ma Y; Yuan RQ; Fan S; Hu C; Goldberg ID; Laterra JJ; Rosen EM
Anticancer Drugs; 2006 Aug; 17(7):733-51. PubMed ID: 16926624
[TBL] [Abstract][Full Text] [Related]
12. [Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].
Dmitrenko VV; Ershov AV; Stetsiuk PI; Likhovid AP; Laptin IuP; Shvarts DR; Mekler AA; Kavsan VM
Tsitol Genet; 2014; 48(6):45-55. PubMed ID: 25536822
[TBL] [Abstract][Full Text] [Related]
13. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations of PTEN in glioblastoma multiforme.
Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
[TBL] [Abstract][Full Text] [Related]
15. Genomics of human glioblastoma multiforme: a glimpse of the future.
Komotar RJ; Syed ON; Bruce JN; Connolly ES; Dunn IF; Friedlander RM
Neurosurgery; 2008 Dec; 63(6):15. PubMed ID: 19057310
[No Abstract] [Full Text] [Related]
16. Genomics illuminates a deadly brain cancer.
Kuehn BM
JAMA; 2010 Mar; 303(10):925-7. PubMed ID: 20215599
[No Abstract] [Full Text] [Related]
17. Genetic analyses for predictors of radiation response in glioblastoma.
Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739
[TBL] [Abstract][Full Text] [Related]
18. Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM.
Quezado M; Ronchetti R; Rapkiewicz A; Santi M; Blumenthal DT; Rushing EJ
Clin Neuropathol; 2005; 24(4):163-9. PubMed ID: 16033132
[TBL] [Abstract][Full Text] [Related]
19. Impact of molecular profiling on clinical trial design for glioblastoma.
Chakravarti A; Tyndall E; Palanichamy K; Mehta M; Aldape K; Loeffler J
Curr Oncol Rep; 2007 Jan; 9(1):71-9. PubMed ID: 17164051
[TBL] [Abstract][Full Text] [Related]
20. SnapShot: glioblastoma multiforme.
Kotliarova S; Fine HA
Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
